Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

FLUCONAZOLE TABLETS

Closed
SPE2DP-26-T-4746Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
Federal
6505--Latanoprost Ophthalmic Solution (VA-27-00006027)
Solicitation # 36E79727R0039
The Department of Veterans Affairs is soliciting proposals for the procurement of Latanoprost 0.005% Ophthalmic Solution to ensure an uninterrupted supply for the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted commercial item procurement is structured into two groups, with one award made in the aggregate for either Group I (single bottles) or Group II (single and bulk cartons). The resulting contract will consist of a one-year base period followed by four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to deliver supplies to designated distribution centers based on business-to-business agreements. Award will be granted based on the lowest evaluated price among proposals that meet all non-cost acceptability standards. Offerors must provide a unique 11-digit NDC number and adhere to the American Academy of Ophthalmology’s uniform color-coding system for caps and labels. Strict compliance with FDA current Good Manufacturing Practice standards is required, and offerors must certify they possess the necessary NDA, ANDA, or BLA approvals. Additionally, products must meet rigorous barcoding and serialization requirements under the Drug Supply Chain Security Act, including the use of GS-1 data matrix codes. Proposals must be submitted by November 17, 2026, and must include a 0.5% cost recovery fee embedded in the pricing.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 17 days
NAICS: 325412
New
Federal
6505--FY27 Lenalidomide BPA
Solicitation # 36C26227Q0083
The Department of Veterans Affairs, through Network Contracting Office 22, has issued this Sources Sought Notice and Request for Information to identify qualified sources for a Health Service Area 5.3 Blanket Purchase Agreement. The government seeks providers capable of supplying Lenalidomide medication in multiple dosage strengths, specifically 2.5mg, 5mg, 10mg, 15mg, 20mg, and 25mg oral capsules. The medication will be delivered to eight participating VA Medical Centers across Arizona, California, and New Mexico. Due to the nature of the medication, the contractor must hold Food and Drug Administration Risk Evaluation and Mitigation Strategy certification to dispense the product and must ensure strict adherence to handling, storage, and temperature control regulations to maintain medication integrity. This is not a formal solicitation, and responses are intended for market research and planning purposes to inform future acquisition decisions. The anticipated period of performance is one year from the date of award, with orders placed on an as-needed basis via approved purchase orders. Interested respondents must provide a comprehensive capabilities statement, business size status relative to NAICS 325412, and details regarding their status as a manufacturer or authorized distributor. Submissions must also address compliance with the Buy American Act, the Non-Manufacturer Rule, and limitations on subcontracting. All responses must be submitted via email to the designated contracting officer by November 12, 2026.
262-NETWORK Contract Office 22 (36C262)

POSTED

1 day ago

DEADLINE

in 12 days

AI Contract Overview

Show more

This contract is for the procurement of Fluconazole 150 mg tablets, supplied in individually sealed blister strips of 12 tablets each. The order consists of two packages under NSN 6505013953039, with a delivery requirement of 20 days after order. The items must be delivered FOB destination and adhere to a strict quantity variance of plus or minus 0 percent. The tablets must have a non-extendable shelf life of 24 months, and no more than 3 months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging and marking must comply with Medical Marking Standard No. 1 and DLA packaging requirements, ensuring the use of suitable commercial exterior containers to protect the contents from damage. Additionally, the supplier must ensure that mercury or mercury-containing compounds are not intentionally added to the supplies.

General Info

Procurement of Fluconazole 150mg tablets, NSN 6505013953039, delivered within 20 days.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

21287 LIGHT INFANTRY AVENUE, FORT BLISS, TX, 79918-2527, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this first21 pages · rfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
FLUCONAZOLE TABLETS
FLUCONAZOLE TABLETS 150 MG
INDIVIDUALLY SEALED BLISTER STRIP CONTAINING 12 TABLETS
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
UNIT OF ISSUE "PACKAGE"
SHALL HAVE A SHELF LIFE OF 24 MONTHS.
NOT MORE THAN 3 MONTHS SHALL HAVE ELAPSED FROM
DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE
GOVERNMENT.
MARK IN ACCORDANCE WITH MMS No. 1B 30 March 2017 MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS; AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA. PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR MERCURY COMPOUND. (IAW NAVSEA 5100-003D). .
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
SPE2DP-26-T-4746
SECTION B
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
NSN 6505013953039
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
ANIP ACQUISITION CO 52BX0 P/N NDC62559-0992-12 GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0426-12
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018012524 0001 PG 2.000
NSN/MATERIAL:6505013953039
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-395-3039 Quantity: 2 PG Purchase Request: 7018012524QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS